SRC inks SR1bn mortgage portfolio deal with Bidaya Finance

SRC inks SR1bn mortgage  portfolio deal with Bidaya Finance
The agreement was signed by SRC CEO Majeed Al-Abduljabbar and Bidaya Finance CEO Mahmoud Dahdouli, in the presence of Minister of Municipalities and Housing Majid Al-Hogail and Chairman of Bidaya Finance Abdulaziz Al-Omair.
Short Url
Updated 05 January 2025
Follow

SRC inks SR1bn mortgage portfolio deal with Bidaya Finance

SRC inks SR1bn mortgage  portfolio deal with Bidaya Finance

The Saudi Real Estate Refinance Company, a Public Investment Fund company, has signed an agreement to acquire a SR1 billion ($266.6 million) mortgage portfolio from Bidaya Finance. The signing ceremony took place in the presence of Minister of Municipalities and Housing and Chairman of SRC Majid bin Abdullah Al-Hogail and Chairman of Bidaya Finance Abdulaziz bin Saleh Al-Omair.

The agreement, signed by SRC CEO Majeed bin Fahad Al-Abduljabbar and Bidaya Finance CEO Mahmoud Dahdouli, marks a continuation of SRC’s ongoing efforts to bolster the residential real estate finance market in the Kingdom and expand refinancing opportunities. 

This portfolio, the largest among mortgage companies, underscores the commitment of both parties to deliver innovative mortgage solutions to citizens and to contribute to the goals of the Housing Program, a key initiative of Saudi Vision 2030, which aims to increase homeownership among citizens.

Al-Abduljabbar said the agreement is part of an expanded partnership with Bidaya Finance, to inject additional liquidity and boost stability in the Kingdom’s real estate finance market. “The agreement is a significant step toward achieving the strategic objectives of the Housing Program by offering flexible financing solutions to Saudi families,” he added.

“It is a key step in our efforts to forge strategic partnerships with leading financial institutions, aimed at developing an active secondary market for residential real estate financing in the Kingdom.”

Dahdouli, meanwhile, said: “This agreement with SRC represents a strategic milestone in strengthening our role in providing innovative financing solutions that contribute to the development of the securities market through mortgage portfolios.

“It also aligns with our vision to empower a brighter financial future for our clients to achieve their aspirations and meet their needs, aligning with the objectives of the Housing Program under the Kingdom’s Vision 2030 to increase homeownership among citizens.”

The SRC was established by the PIF in 2017 to develop the Kingdom’s real estate finance market. Licensed by the Saudi Central Bank to operate in the field of real estate refinancing, SRC plays a pivotal role in achieving the objectives of the Housing Program under Saudi Vision 2030, which seeks to increase homeownership rates among Saudi citizens. This is accomplished by providing liquidity to financiers, enabling them to offer affordable housing finance to individuals, and working closely with partners to support the Kingdom’s housing ecosystem.


Wesam Medical and McLaren Health Care to bring new hematology & oncology hospital to Riyadh

Wesam Medical and McLaren Health Care to bring new hematology & oncology hospital to Riyadh
Updated 03 November 2025
Follow

Wesam Medical and McLaren Health Care to bring new hematology & oncology hospital to Riyadh

Wesam Medical and McLaren Health Care to bring new hematology & oncology hospital to Riyadh

Wesam Medical Holding, a Saudi healthcare investment company, has announced the signing of a strategic MoU with McLaren Health Care, one of the largest healthcare systems in the state of Michigan, US, and operator of the Karmanos Cancer Institute, to establish a specialized hematology and oncology hospital in Riyadh.

Under the terms of the MoU, Wesam Medical Holding will oversee all legal, regulatory, and local market operations, while McLaren Health Care will be responsible for clinical, operational, and technical components, including hospital design and construction.

This partnership marks a significant milestone in Saudi Arabia’s healthcare sector, representing McLaren’s entry into the Kingdom to provide comprehensive, integrated services for hematology and oncology patients. The collaboration will extend the reach of the system’s renowned Karmanos Cancer Institute, designated by the US National Cancer Institute as a Comprehensive Cancer Center.

The MoU was signed by Fahad Ibrahim Al-Khalaf, chairman of Wesam Medical Holding Company, and Dr. Barton Buxton, president and chief executive of McLaren Health Management Group, a subsidiary of McLaren Health Care. The partnership aims to transform oncology services in the Kingdom, aligning with the objectives of the Healthcare Sector Transformation Program.

The hospital represents the first standalone private comprehensive cancer center in the Kingdom, delivering fully integrated services across hematology and oncology disciplines. It provides high-quality care through Saudi consultants and a multidisciplinary team of highly qualified professionals.

The partnership with McLaren Health Care reflects a shared vision to advance clinical excellence, adopt state-of-the-art technologies, and apply internationally recognized best practices in cancer care and precision medicine.

Al-Khalaf said: “This partnership represents an important milestone in realizing our investment vision, which focuses on long-term strategic ventures that add sustainable value to the Kingdom’s healthcare sector. Following the completion of the feasibility study for the hematology and oncology hospital, we are pleased to launch this ambitious project in collaboration with McLaren Health Care, a system recognized globally for its excellence in oncology. Together, we will integrate our local expertise with McLaren’s clinical and technical capabilities to deliver specialized healthcare services of the highest international standards.”

Dr. Buxton said: “Our collaboration with Wesam Medical Holding marks a significant step in McLaren Health Care’s global strategy. Through this partnership, we aim to extend our mission of delivering value-based healthcare through clinical excellence and cost efficiency beyond the US. Wesam Medical’s deep understanding of the Saudi healthcare landscape makes it an ideal partner. Together, we will integrate Karmanos Cancer Institute’s world-class oncology standards into the Kingdom’s healthcare system, beginning with Riyadh.”

Prior to signing this memorandum, Wesam Medical conducted a detailed feasibility study for the establishment of the hospital in collaboration with a specialized healthcare consulting firm.

The hospital’s key strategic objectives and pillars include:

  1. Meeting the rising demand for specialized oncology services: Addressing the growing need for high-quality hematology and oncology care through the private sector, reducing the burden on government-run referral hospitals, and ensuring access to world-class care within the Kingdom.
  2. Leveraging McLaren’s expertise: Bringing the clinical and operational excellence of McLaren Health Care and its subsidiary, the Karmanos Cancer Institute, one of the leading oncology and research institutions in the US, to strengthen clinical research and national disease registries in Saudi Arabia.
  3. Enhancing national workforce efficiency: Providing advanced training and professional development for Saudi physicians, nurses, and administrative personnel through knowledge transfer from McLaren and Karmanos experts, thereby improving the overall quality of healthcare services in the Kingdom.
  4. Transferring American knowledge and technology: Ensuring the delivery of diagnostic and therapeutic services that meet the highest international standards and align with the Kingdom’s vision for medical innovation and sustainability.